Proline

Proline

SCHEMBL4596015

O=C(O)C1CCCN1.O=C1NCCNC1=O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
DPP4 P27487 4/20 0.40
DPP8 Q6V1X1 2/20 0.40
DPP9 Q86TI2 2/20 0.40
NOS2 P35228 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
ELANE P08246 1/20 0.38
SCN4A P35499 1/20 0.36
FAP Q12884 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
PARP1 P09874 1/20 0.35
PRCP P42785 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL4596023 1.00 MEN1 (0.41) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL8180643 0.90 NOS2 (0.37) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL11588329 0.86 MEN1 (0.42) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL28281079 0.86 BLM (0.48) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL4309382 0.86 BLM (0.48) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL2173873 0.86 BLM (0.48) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL4309380 0.86 BLM (0.48) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL10141185 0.85
Proline SCHEMBL462226 0.85 BLM (0.52) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL718906 0.85 BLM (0.52) MEN1BLMKMT2ADPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002001956-A1 HISTIDYL-PROLINE DIKETOPIPERAZINE AND METHOD OF USE PRASAD CHANDAN (US) 2002-01-10 WO claimed
CN-105744945-B Three peptide formulations of freeze-drying of stable storing 广州领晟医疗科技有限公司 2019-07-02 CN disclosed
EP-1442741-B1 Compositions and methods for treating obesity US DEPT OF VETERANS AFFAIRES A (US) 2008-01-16 EP disclosed
US-7144865-B2 Compositions and methods for treating obesity THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2006-12-05 US disclosed
US-20040185125-A1 Compositions and methods for treating obesity UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2004-09-23 US disclosed
EP-1442741-A1 Compositions and methods for treating obesity Moon, K. Song (US) 2004-08-04 EP disclosed
WO-2002001956-A1 HISTIDYL-PROLINE DIKETOPIPERAZINE AND METHOD OF USE PRASAD CHANDAN (US) 2002-01-10 WO disclosed
EP-0220958-A2 Selective chemical removal of a protein amino-terminal residue ELI LILLY AND COMPANY (US) 1987-05-06 EP disclosed